Form 8-K - Current report:
SEC Accession No. 0001140361-21-028006
Filing Date
2021-08-12
Accepted
2021-08-12 07:31:17
Documents
57
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10027978_8k.htm 8-K 21086
2 EXHIBIT 99.1 brhc10027978_ex99-1.htm EX-99.1 139827
3 EXHIBIT 99.2 brhc10027978_ex99-2.htm EX-99.2 105927
4 brhc10027978_ex99-2slide2.jpg GRAPHIC 379961
5 brhc10027978_ex99-2slide54.jpg GRAPHIC 86014
6 brhc10027978_ex99-2slide56.jpg GRAPHIC 244631
7 brhc10027978_ex99-2slide57.jpg GRAPHIC 188049
8 brhc10027978_ex99-2slide58.jpg GRAPHIC 213515
9 brhc10027978_ex99-2slide59.jpg GRAPHIC 185330
10 brhc10027978_ex99-2slide60.jpg GRAPHIC 137895
11 brhc10027978_ex99-2slide61.jpg GRAPHIC 59339
12 brhc10027978_ex99-2slide62.jpg GRAPHIC 148731
13 brhc10027978_ex99-2slide63.jpg GRAPHIC 153393
14 brhc10027978_ex99-2slide64.jpg GRAPHIC 62152
15 brhc10027978_ex99-2slide65.jpg GRAPHIC 158224
16 brhc10027978_ex99-2slide66.jpg GRAPHIC 189877
17 brhc10027978_ex99-2slide67.jpg GRAPHIC 191535
18 brhc10027978_ex99-2slide68.jpg GRAPHIC 171611
19 brhc10027978_ex99-2slide69.jpg GRAPHIC 157061
20 brhc10027978_ex99-2slide70.jpg GRAPHIC 171280
21 brhc10027978_ex99-2slide71.jpg GRAPHIC 161622
22 brhc10027978_ex99-2slide72.jpg GRAPHIC 205558
23 brhc10027978_ex99-2slide73.jpg GRAPHIC 191320
24 brhc10027978_ex99-2slide74.jpg GRAPHIC 62428
25 brhc10027978_ex99-2slide75.jpg GRAPHIC 177643
26 brhc10027978_ex99-2slide76.jpg GRAPHIC 165258
27 brhc10027978_ex99-2slide77.jpg GRAPHIC 190641
28 brhc10027978_ex99-2slide78.jpg GRAPHIC 196838
29 brhc10027978_ex99-2slide79.jpg GRAPHIC 151609
30 brhc10027978_ex99-2slide80.jpg GRAPHIC 153596
31 brhc10027978_ex99-2slide81.jpg GRAPHIC 161130
32 brhc10027978_ex99-2slide82.jpg GRAPHIC 152218
33 brhc10027978_ex99-2slide83.jpg GRAPHIC 211637
34 brhc10027978_ex99-2slide84.jpg GRAPHIC 180324
35 brhc10027978_ex99-2slide85.jpg GRAPHIC 172189
36 brhc10027978_ex99-2slide86.jpg GRAPHIC 62244
37 brhc10027978_ex99-2slide87.jpg GRAPHIC 181503
38 brhc10027978_ex99-2slide88.jpg GRAPHIC 164784
39 brhc10027978_ex99-2slide89.jpg GRAPHIC 136578
40 brhc10027978_ex99-2slide90.jpg GRAPHIC 150836
41 brhc10027978_ex99-2slide91.jpg GRAPHIC 69726
42 brhc10027978_ex99-2slide92.jpg GRAPHIC 193395
43 brhc10027978_ex99-2slide93.jpg GRAPHIC 203057
44 brhc10027978_ex99-2slide94.jpg GRAPHIC 204255
45 brhc10027978_ex99-2slide95.jpg GRAPHIC 203244
46 brhc10027978_ex99-2slide96.jpg GRAPHIC 155039
47 brhc10027978_ex99-2slide97.jpg GRAPHIC 150021
48 brhc10027978_ex99-2slide98.jpg GRAPHIC 181095
49 brhc10027978_ex99-2slide99.jpg GRAPHIC 37247
50 brhc10027978_ex99-2slide100.jpg GRAPHIC 174709
51 brhc10027978_ex99-2slide101.jpg GRAPHIC 171726
52 brhc10027978_ex99-2slide102.jpg GRAPHIC 205820
53 brhc10027978_ex99-2slide103.jpg GRAPHIC 117878
54 brhc10027978_ex99-2slide104.jpg GRAPHIC 85193
55 brhc10027978_ex99-2slide105.jpg GRAPHIC 146717
56 brhc10027978_ex99-2slide106.jpg GRAPHIC 178769
57 image00001.jpg GRAPHIC 5658
  Complete submission text file 0001140361-21-028006.txt   12134807
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 211165502
SIC: 2834 Pharmaceutical Preparations